Professor Antoine Rimbert, University of Nantes, France, discusses the challenges of reducing secretion of VLDL without inducing liver steatosis, and considers common gene variants associated with decreases in both apoB and plasma liver enzymes, such as GPR146.
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
